Treatment of Severe Atopic Dermatitis With Upadacitinib in Clinical Practice: Short-Term Efficacy and Safety Results

被引:11
|
作者
Pereyra-Rodriguez, J. J. [1 ,17 ]
Herranz, P. [2 ]
Figueras-Nart, I [3 ]
Perez, B. [4 ]
Elosua, M. [5 ]
Munera-Campos, M. [6 ]
Melgosa-Ramos, J. [7 ]
Zaragoza, V [8 ]
Silvestre, J. F. [9 ]
Campos-Dominguez, M. [10 ]
Guilabert, A. [11 ]
Miquel, J. [12 ]
Alcantara-Luna, S. [13 ]
de la Cueva, P. [14 ]
Serra-Baldrich, E. [15 ]
Armario-Hita, J. C. [16 ]
Rodriguez, Jose Juan Pereyra
机构
[1] Univ Hosp Virgen Rocio, Dept Dermatol, Seville, Spain
[2] Univ Hosp La Paz, Dept Dermatol, Madrid, Spain
[3] Univ Hosp Bellvitge, Dept Dermatol, Barcelona, Spain
[4] Univ Hosp Ramon & Cajal, Dept Dermatol, Madrid, Spain
[5] Univ Hosp Puerta Hierro, Dept Dermatol, Madrid, Spain
[6] Univ Hosp Germans Trias i Pujol, Dept Dermatol, Badalona, Spain
[7] Univ Hosp Doctor Peset, Dept Dermatol, Valencia, Spain
[8] Univ Hosp Gen Valencia, Dept Dermatol, Valencia, Spain
[9] Univ Hosp Alicante, Dept Dermatol, Alicante, Spain
[10] Univ Hosp Gregorio Maranon, Dept Dermatol, Madrid, Spain
[11] Gen Hosp Granollers, Dept Dermatol, Barcelona, Spain
[12] Univ Hosp Arnau Vilanova, Dept Dermatol, Valencia, Spain
[13] Juan Ramon Jimenez Hosp, Dept Dermatol, Huelva, Spain
[14] Infanta Leonor Hosp, Dept Dermatol, Madrid, Spain
[15] St Pau Hosp, Dept Dermatol, Barcelona, Spain
[16] Univ Hosp Puerto Real, Dept Dermatol, Puerto Real, Spain
[17] Univ Hosp Virgen del Roci, Dept Dermatol, Avda Manuel Siurot S-N, Seville 41013, Spain
关键词
Atopic dermatitis; Atopic eczema; Upadacitinib; JAK-inhibitors; Real-world evidence; DOUBLE-BLIND; ADOLESCENTS; PLACEBO; ADULTS;
D O I
10.18176/jiaci.0831
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:211 / 213
页数:3
相关论文
共 50 条
  • [41] Short-Term Efficacy and Safety Outcomes of Brolucizumab in the Real-Life Clinical Practice
    Montesel, Andrea
    Bucolo, Claudio
    Sallo, Ferenc B.
    Eandi, Chiara M.
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [42] Comparative efficacy and safety of abrocitinib, baricitinib, and upadacitinib for moderate-to-severe atopic dermatitis: A network meta-analysis
    Wan, Huiying
    Jia, Haiping
    Xia, Tian
    Zhang, Dingding
    DERMATOLOGIC THERAPY, 2022, 35 (09)
  • [43] A real-world Australian experience of upadacitinib for the treatment of severe atopic dermatitis
    Tran, Vanessa
    Ross, Gayle
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2023, 64 (04) : e352 - e356
  • [44] Long-term effectiveness and safety of upadacitinib for Japanese patients with moderate-to-severe atopic dermatitis: a real-world clinical study
    Hagino, Teppei
    Saeki, Hidehisa
    Fujimoto, Eita
    Kanda, Naoko
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2024, 35 (01)
  • [45] Efficacy and safety of upadacitinib vs dupilumab treatment for moderate to severe atopic dermatitis in four body regions - Analysis from the Heads Up Study
    Thyssen, Jacob P.
    Rosmarin, David
    Costanzo, Antonio
    Warren, Richard B.
    Ladizinkski, Barry
    Hu, Xiaofei
    Nduaka, Chudi
    Vigna, Namita
    Armstrong, April
    CLINICAL AND EXPERIMENTAL ALLERGY, 2022, 52 (08): : 998 - 999
  • [46] Efficacy and safety of upadacitinib in the treatment of moderate-to-severe atopic dermatitis in adolescents: A systematic review and meta-analysis of randomized controlled trials
    Huang, Lingmei
    Zhao, Danjie
    Lin, Haixia
    Zheng, Hong
    Li, Xia
    Chen, Long
    Tang, Peng
    MEDICINE, 2024, 103 (38)
  • [47] Upadacitinib in Moderate-to-Severe Atopic Dermatitis: Real-Life Study of Long-Term Efficacy, Safety and Correlation Between Clinical Effectiveness and Subjective Perception of Disease
    Bertello, M.
    Cinotti, E.
    Rubegni, P.
    Mastorino, L.
    Passaro, G.
    Ortoncelli, M.
    Quaglino, P.
    Ribero, S.
    DERMATITIS, 2024,
  • [48] Dual Efficacy of Upadacitinib in 2 Patients With Concomitant Severe Atopic Dermatitis and Alopecia Areata
    Gambardella, Alessio
    Licata, Gaetano
    Calabrese, Giulia
    De Rosa, Alina
    Alfano, Roberto
    Argenziano, Giuseppe
    DERMATITIS, 2021, 32 (1S) : E85 - E86
  • [49] Short-term efficacy and safety of lurasidone in the treatment of schizophrenia
    Samalin, L.
    Ben Gharbia, M.
    Garnier, M.
    Llorca, P. -M.
    ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2014, 40 (06): : 507 - 517
  • [50] Ruxolitinib cream for the short-term treatment of mild-moderate atopic dermatitis
    Krajewski, Piotr K.
    Szepietowski, Jacek C.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2023, 19 (04) : 349 - 356